These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37973660)

  • 1. Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion.
    Wahid M; Pratoomthai B; Egbuniwe IU; Evans HR; Babaei-Jadidi R; Amartey JO; Erdelyi V; Yacqub-Usman K; Jackson AM; Morris JC; Patel PM; Bates DO
    Cancer Immunol Immunother; 2023 Dec; 72(12):4001-4014. PubMed ID: 37973660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of serine/arginine-rich protein kinase-1 (SRPK1) prevents cholangiocarcinoma cells induced angiogenesis.
    Supradit K; Boonsri B; Duangdara J; Thitiphatphuvanon T; Suriyonplengsaeng C; Kangsamaksin T; Janvilisri T; Tohtong R; Yacqub-Usman K; Grabowska AM; Bates DO; Wongprasert K
    Toxicol In Vitro; 2022 Aug; 82():105385. PubMed ID: 35568131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRPK Inhibitors Reduce the Phosphorylation and Translocation of SR Protein Splicing Factors, thereby Correcting
    Changphasuk P; Inpad C; Horpaopan S; Khunchai S; Phimsen S; Surangkul D; Janvilisri T; Silsirivanit A; Kaewkong W
    Front Biosci (Schol Ed); 2024 Sep; 16(3):17. PubMed ID: 39344395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells.
    Gonçalves V; Henriques AF; Pereira JF; Neves Costa A; Moyer MP; Moita LF; Gama-Carvalho M; Matos P; Jordan P
    RNA; 2014 Apr; 20(4):474-82. PubMed ID: 24550521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splicing kinase SRPK1 conforms to the landscape of its SR protein substrate.
    Aubol BE; Jamros MA; McGlone ML; Adams JA
    Biochemistry; 2013 Oct; 52(43):7595-605. PubMed ID: 24074032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma.
    Liu H; Gong Z; Li K; Zhang Q; Xu Z; Xu Y
    J Exp Clin Cancer Res; 2021 Feb; 40(1):75. PubMed ID: 33602301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1.
    Wagner KD; El Maï M; Ladomery M; Belali T; Leccia N; Michiels JF; Wagner N
    Cells; 2019 Jan; 8(1):. PubMed ID: 30641926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Extended PD-L2 Cytoplasmic Domain Results From Alternative Splicing in NSCLC Cells.
    Dietz LL; Furman NT; Larsen TV; Daugaard TF; Thomsen EA; Keller JL; Aagaard L; Sorensen BS; Nielsen AL
    J Immunother; 2022 Nov-Dec 01; 45(9):379-388. PubMed ID: 36036966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine and arginine rich splicing factor 1 deficiency alters pathways involved in IL-17A expression and is implicated in human psoriasis.
    Su S; Katopodi XL; Pita-Juarez YH; Maverakis E; Vlachos IS; Adamopoulos IE
    Clin Immunol; 2022 Jul; 240():109041. PubMed ID: 35613697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.
    Thorsen K; Mansilla F; Schepeler T; Øster B; Rasmussen MH; Dyrskjøt L; Karni R; Akerman M; Krainer AR; Laurberg S; Andersen CL; Ørntoft TF
    Mol Cell Proteomics; 2011 Jan; 10(1):M110.002998. PubMed ID: 20938052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular interactions connecting the function of the serine-arginine-rich protein SRSF1 to protein phosphatase 1.
    Aubol BE; Serrano P; Fattet L; Wüthrich K; Adams JA
    J Biol Chem; 2018 Oct; 293(43):16751-16760. PubMed ID: 30185622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus type 16 infection activates the host serine arginine protein kinase 1 (SRPK1) - splicing factor axis.
    Mole S; Faizo AAA; Hernandez-Lopez H; Griffiths M; Stevenson A; Roberts S; Graham SV
    J Gen Virol; 2020 May; 101(5):523-532. PubMed ID: 32182205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3.
    Wang X; Yan L; Guo J; Jia R
    Int Immunopharmacol; 2024 Jan; 126():111280. PubMed ID: 38043270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-domain Cross-talk Regulates Serine-arginine Protein Kinase 1-dependent Phosphorylation and Splicing Function of Transformer 2β1.
    Jamros MA; Aubol BE; Keshwani MM; Zhang Z; Stamm S; Adams JA
    J Biol Chem; 2015 Jul; 290(28):17269-81. PubMed ID: 26013829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Mechanism of SR Protein Kinase 1 Inhibition by the Herpes Virus Protein ICP27.
    Tunnicliffe RB; Hu WK; Wu MY; Levy C; Mould AP; McKenzie EA; Sandri-Goldin RM; Golovanov AP
    mBio; 2019 Oct; 10(5):. PubMed ID: 31641093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine-arginine-rich protein kinase-1 inhibition for the treatment of diabetic retinopathy.
    Malhi NK; Allen CL; Stewart E; Horton KL; Riu F; Batson J; Amoaku W; Morris JC; Arkill KP; Bates DO
    Am J Physiol Heart Circ Physiol; 2022 Jun; 322(6):H1014-H1027. PubMed ID: 35302878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain.
    Hulse RP; Drake RA; Bates DO; Donaldson LF
    Neurobiol Dis; 2016 Dec; 96():186-200. PubMed ID: 27616424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma.
    Gammons MV; Lucas R; Dean R; Coupland SE; Oltean S; Bates DO
    Br J Cancer; 2014 Jul; 111(3):477-85. PubMed ID: 25010863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer.
    Mavrou A; Brakspear K; Hamdollah-Zadeh M; Damodaran G; Babaei-Jadidi R; Oxley J; Gillatt DA; Ladomery MR; Harper SJ; Bates DO; Oltean S
    Oncogene; 2015 Aug; 34(33):4311-9. PubMed ID: 25381816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors.
    Colwill K; Feng LL; Yeakley JM; Gish GD; Cáceres JF; Pawson T; Fu XD
    J Biol Chem; 1996 Oct; 271(40):24569-75. PubMed ID: 8798720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.